Cargando…
Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins
Autores principales: | Rana, Indrajeetsinh, Kompa, Andrew R., Skommer, Joanna, Wang, Bing H., Lekawanvijit, Suree, Kelly, Darren J., Krum, Henry, Charchar, Fadi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510638/ https://www.ncbi.nlm.nih.gov/pubmed/26109195 http://dx.doi.org/10.14814/phy2.12452 |
Ejemplares similares
-
Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins
por: Rana, Indrajeetsinh, et al.
Publicado: (2015) -
Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uremic Toxin, Indoxyl Sulfate
por: Lekawanvijit, Suree, et al.
Publicado: (2012) -
The Uremic Toxin Adsorbent AST-120 Abrogates Cardiorenal Injury Following Myocardial Infarction
por: Lekawanvijit, Suree, et al.
Publicado: (2013) -
Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
por: Lekawanvijit, Suree
Publicado: (2018) -
Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death
por: Skommer, J, et al.
Publicado: (2014)